Abbott Strikes Back At Bayer Patent Suit Over Humira

By Brendan Pierson

Law360, New York (January 06, 2009, 12:00 AM ET) -- Abbott Laboratories has sued Bayer HealthCare LLC for a judgment that a Bayer patent is invalid and unenforceable, firing back at an infringement suit Bayer filed recently seeking to assert the patent against Abbott's hugely popular arthritis drug Humira.

In a complaint filed Monday in the U.S. District Court for the District of Massachusetts, Abbott asked for a declaration that Humira does not infringe U.S. Patent Number 5,654,407, titled “Human anti-TNF antibodies,” and that the '407 patent is invalid and unenforceable under the doctrine of laches,...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles